Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IκBα degradation and RelA activation

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 856-863

  Pioli, Claudio ^a   Gatta, Lucia ^a   Frasca, Daniela ^a   Doria, Gino ^b  

^a ENEA C R CASACCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CD28; CTLA 4; IL 2; I B ; RelA

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0033024389     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199903)29:03<856::aid-immu856>3.0.co;2-p     Document Type: Article

References (43)

1. Springer, T. A., Adhesion receptors of the immune system. Nature 1990. 346: 425-434.
2. Weaver, C. T. and Unanue, E. R., The costimulatory function of antigen presenting cells. Immunol. Today 1990. 11: 49-55.
3. Schwartz, R. H., A cell culture model for T lymphocytes clonal anergy. Science 1990. 248: 1349-1356.
4. Jenkins, M. K. and Schwarz, R. H., Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 1987. 165: 302-319.
5. Chai, J. G. and Lechler, R. I., Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro. Int. Immunol. 1997. 9: 935-944.
6. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
7. June, C. H., Ledbetter, J. A., Linsley, P. S. and Thompson, C. B., Role of the CD28 receptor in T-cell activation. Immunol. Today 1990. 11: 211-216.
8. Harper, K., Balzano, C., Rouvier, E., Mattei, M. G., Luciani, M. F. and Golstein, P., CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 1991. 147: 1037-1044.
9. Gross, J. A., Callas, E. and Allison, J. P., Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992. 149: 380-388.
10. Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C. and Damle, N. K., Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 1992. 176: 1595-1604.
11. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
12. Finn, P. W., He, H., Wang, Y., Wang, Z., Guan, G., Listman, J. and Perkins, D. L., Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J. Immunol. 1997. 158: 4074-4081.
13. Krummel, M. F. and Allison, J. P., CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995. 182: 459-465.
14. Kearney, E. R., Walunas, T. L., Karr, R. W., Morton, P. A., Loh, D. Y., Bluestone, J. A. and Jenkins, M. K., Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 1995. 155: 1032-1036.
15. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A., CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996. 183: 2541-2550.
16. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P. and Bluestone, J. A., Loss of CTLA-4 leads to massive lymphoproliteration and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
17. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995. 270: 985-988.
18. Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B., Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989. 244: 339-343.
19. Lai, J. H. and Tan, T. H., CD28 signaling causes a sustained down-regulation of I(greek small letter script kappa)Bα which can be prevented by rapamycin. J. Biol. Chem. 1994. 269: 30077-30080.
20. Harhaj, E. W., Maggirwar, S. B., Good, L. and Sun, S. C., CD28 mediates a potent costimulatory signal for rapid degradation of I(greek small letter script kappa)Bβ which is associated with accelerated activation of various NF(greek small letter script kappa)B/Rel heterodimers. Mol. Cell. Biol. 1996. 16: 6736-6743.
21. Ghosh, P., Tan, T. H., Rice, N. R., Sica, A. and Young, H. A., The interleukin 2 CD28-responsive complex contains at least three members of the NF (greek small letter script kappa)B family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 1993. 90: 1696-1700.
22. Baldwin, A. S. Jr., The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 1996. 14: 649-681.
23. Akira, S. and Kishimoto, T., NF-IL6 and NF-(greek small letter script kappa)B in cytokine gene regulation. Adv. Immunol. 1997. 65: 1-46.
24. + cells from young and old mice. Immunology 1998. 94: 380-387.
25. Lai, J. H., Horvath, G., Subleski, J., Bruder, J., Ghosh, P. and Tan, T. H., ReIA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell Biol. 1995. 15: 4260-4271.
26. Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996. 183: 2533-2540.
27. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, G. S. and Gray, G. S., Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 1993. 151: 3489-3499.
28. Fraser, J. D., Iriving, B. A., Crabtree, G. R. and Weiss, A., Regulation of interleukin-2 enhancer activity by the T cell accessory molecule CD28. Science 1991. 251: 313-316.
29. Verweij, C. L., Geerts, M. and Aarden, L. A., Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J. Biol. Chem. 1991. 266: 14179-14182.
30. Sica, A., Tan, T. H., Rice, N. R., Kretzschmar, M., Ghosh, P. and Young, H. A., The c-rel protooncogene product c-Rel but not NF-(greek small letter script kappa)B binds to the intronic region of the human interferon-y gene at a site related to an interferon-stimulable response element. Proc. Natl. Acad. Sci. USA 1992. 89: 1740-1744.
31. Tan, T. H., Huang, G. P., Sica, A., Ghosh, P., Young, H. A., Longo, D. L. and Rice, N. R., kB site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Mol. Cell Biol. 1992. 12: 4067-4075.
32. Baeuerle, P. A. and Baichwal, V. R., NF-kB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 1997. 65: 111-137.
33. Finco, T. S., Beg, A. A. and Baldwin, A. S. Jr., Inducible phosphorylation of IkBa is not sufficient for its dissociation from NFkB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 1994. 91: 11884-11888.
34. Matthew, J. R. and Hay, R. T., Regulation of the DNA binding activity of NF(greek small letter script kappa)B. Int. J. Biochem. Cell Biol. 1995. 27: 865-879.
35. Siebenlist, U., Franzoso, G. and Brown, K., Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol. 1994. 10: 405-455.
36. Marengere, L. E., Waterhouse, P., Duncan, G. S., Mak, T. W. and Feng, G. S., Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996. 272: 1170-1173.
37. Hutchcroft, J. E. and Bierer, B. E., Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. J. Immunol. 1996. 156: 4071-4074.
38. Schneider, H., Prasad, V. S., Shoelson, S. E. and Rudd, C. E., CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 1995. 181: 351-355.
39. Stein, P. H., Fraser, J. D. and Weiss, A., The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell Biol. 1994. 14: 3392-3402.
40. Frasca, D., Pucci, S., Goso, C., Barattini, P., Barile, S., Pioli, C. and Doria, G., Regulation of cytokine production in aging. Use of recombinant cytokines to upregulate mitogen-stimulated spleen cells. Mech. Ageing Dev. 1997. 93: 157-169.
41. Andrews, N. C. and Faller, D. V., A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991. 19: 2499-2504.
42. Fazioli, F., Minichiello, L., Matoskova, B., Wong, T. and Di Fiore, P. P., eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol. Cell Biol. 1993. 13: 5814-5828.
43. Muller, H., Moroni, M. C., Vigo, E., Petersen, B. O., Bartek, J. and Helin, K., Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell Biol. 1997. 17: 5508-5520.